USE OF T-TYPE CALCIUM CHANNEL BLOCKER FOR TREATING RHEUMATOID ARTHRITIS
Provided is a medicinal drug for treating or preventing rheumatoid arthritis. As a medicinal drug for treating or preventing rheumatoid arthritis, the present invention uses, as an active ingredient, a compound that has an effect of blocking the T-type calcium channel (Cav3.2 channel) and that is re...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English French Japanese |
Published |
08.10.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided is a medicinal drug for treating or preventing rheumatoid arthritis. As a medicinal drug for treating or preventing rheumatoid arthritis, the present invention uses, as an active ingredient, a compound that has an effect of blocking the T-type calcium channel (Cav3.2 channel) and that is represented by any one of general formulae (I)-(VI), a tautomer, a stereoisomer, or a pharmaceutically acceptable salt of the compound, or a solvate thereof.
L'invention concerne un produit médicinal servant au traitement ou à la prévention de la polyarthrite rhumatoïde. En tant que produit médicinal servant au traitement ou à la prévention de la polyarthrite rhumatoïde, la présente invention utilise, en tant que principe actif, un composé qui a pour effet de bloquer les canaux calciques de type T (canal Cav3.2) et qui est représenté par l'une quelconque des formules générales (I)- (VI), un tautomère, un stéréoisomère, ou un sel pharmaceutiquement acceptable du composé, ou un solvate de ce dernier.
関節リウマチの治療又は予防のための医薬を提供する。 関節リウマチに対する治療又は予防のための医薬として、一般式(I)~(VI)で表されるT型カルシウムチャネル(Cav3.2チャネル)の阻害作用を有する化合物、該化合物の互変異性体、立体異性体、若しくはその薬学的に許容される塩又はそれらの溶媒和物を有効成分として用いる。 |
---|---|
Bibliography: | Application Number: WO2020JP13543 |